JW Therapeutics
Shanghai based therapeutics platform.
Market cap
$144m
Enterprise value
$100m
Share price
HKD2.86 2126.HK
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | $300m | IPO | |
| Total Funding | 000k | ||
YuanMing Capital(exited)
Juno Therapeutics(exited)
Mirae Asset Capital(exited)
Oriza Holdings(exited)
Loyal Valley Capital(exited)
Temasek(exited)
Sequoia(exited)
ARCH Venture Partners(exited)
CITIC PE(exited)
WuXi AppTec(exited)
HongShan(exited)
| CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 373 % | 19 % | (9 %) | 102 % | 73 % | 49 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (2274 %) | (516 %) | (272 %) | (410 %) | (160 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (2281 %) | (581 %) | (442 %) | (373 %) | (191 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 1346 % | 280 % | 238 % | 179 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.